Muhammad Noor, MD
Geriatric Medicine · Jamaica, NYNPI 1164628376
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 212 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 11.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,971 and has fallen 51.1% since, to $964 in 2025. Among geriatric medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 212 payments — averaging $34.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Melinta Therapeutics, LLC$826
- AbbVie$777
- Pfizer$735
- E.r. Squibb & Sons, L.L.C.$677
- Shionogi Inc$647
- AstraZeneca$578
- plus $3K from 22 others
What the payments were for
- Food & beverage$7,285100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Melinta Therapeutics, LLC | 26 | $826 |
| AbbVie(2 entities) | 39 | $777 |
| Pfizer | 31 | $735 |
| E.r. Squibb & Sons, L.L.C. | 17 | $677 |
| Shionogi Inc | 18 | $647 |
| AstraZeneca | 5 | $578 |
| Otsuka America Pharmaceutical, Inc. | 3 | $362 |
| Merck | 20 | $362 |
| Johnson & Johnson | 15 | $353 |
| Regeneron Healthcare Solutions, Inc. | 4 | $293 |
| Boehringer Ingelheim | 4 | $289 |
| Acadia Pharmaceuticals Inc | 2 | $215 |
| Novartis | 3 | $169 |
| Bayer | 1 | $125 |
| Amgen | 1 | $125 |
| Urovant Sciences Inc | 1 | $120 |
| Mylan Specialty L.p. | 3 | $95 |
| La Jolla Pharmaceutical Company | 4 | $94 |
| Lilly USA, LLC | 2 | $90 |
| Gilead | 3 | $86 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $81 |
| Avanir Pharmaceuticals, Inc. | 1 | $61 |
| Bioxcel Therapeutics, Inc. | 1 | $28 |
| Abbott | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Reprise Biomedical, Inc. | 1 | $20 |
| Medtronic | 1 | $17 |
| Smith+Nephew | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,285 in reported general payments places this provider in the 95th percentile of 400 geriatric medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 213 | $64,033 |
| NuplazidPimavanserin Tartrate | 26 | $63,965 |
| RytaryCarbidopa/Levodopa | 46 | $26,309 |
| SantylCollagenase Clostridium Hist. | 16 | $15,260 |
| XareltoRivaroxaban | 52 | $15,157 |
| Clobetasol Propionate | 44 | $11,553 |
| GemtesaVibegron | 41 | $9,836 |
| Memantine Hcl | 81 | $5,054 |
| JardianceEmpagliflozin | 17 | $4,968 |
| EntrestoSacubitril/Valsartan | 13 | $4,723 |
| JanuviaSitagliptin Phosphate | 12 | $4,235 |
| Memantine Hcl ErMemantine Hcl | 48 | $3,521 |
| Calcipotriene | 18 | $3,451 |
| Levothyroxine Sodium | 242 | $2,104 |
| Duloxetine Hcl | 71 | $1,962 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $735 | $64,033213 claims |
| Acadia Pharmaceuticals IncNuplazid | $215 | $63,96526 claims |
| Smith+NephewSantyl | $16 | $15,26016 claims |
| Johnson & JohnsonXarelto | $353 | $15,15752 claims |
| Boehringer IngelheimJardiance | $289 | $4,96817 claims |
| NovartisEntresto | $169 | $4,72313 claims |
| MerckJanuvia | $362 | $4,23512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 400 geriatric medicine providers in New York.
Other geriatric medicine in Jamaica
- Wen DombrowskiBrooklyn$45K
- Sharon BrangmanSyracuse$45K
- Howard FillitNew York$42K
- Adam CohenGreat Neck$27K
- Inna ShifrinBrooklyn$21K
- Amit SaxenaBronx$16K
- Nirmala TummalapentaBronx$16K
- Nasem SayeghElmsford$15K
- Bruce LowellGreat Neck$14K
- Andre SerretteHewlett$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.